H1N1 Influenza Vaccination Response in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients

Wan-Hee Yoo

doi:10.4078/jrd.2013.20.3.137

Journal List > J Rheum Dis > v.20(3) > 1064032

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Yoo: H1N1 Influenza Vaccination Response in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients

Editorial

J Rheum Dis 2013;20(3):137-139.

Published online: 31 June 2013

DOI: https://doi.org/10.4078/jrd.2013.20.3.137

H1N1 Influenza Vaccination Response in Rheumatoid Arthritis and Systemic Lupus Erythematosus Patients

Wan-Hee Yoo

Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, Korea

Corresponding to : Wan-Hee Yoo, Division of Rheumatology, Department of Internal Medicine, Chonbuk National University Medical School, 20, Geonji-ro, Deokjin-gu, Jeonju 561-712, Korea. E-mail : ywhim@jbnu.ac.kr

Received 21 June 2013 Accepted 26 June 2013

This is a Free Access article, which permits unrestricted non-commerical use, distribution, and reproduction in any medium, provided the original work is properly cited.

References

1. Falagas ME, Manta KG, Betsi GI, Pappas G. Infection-re-lated morbidity and mortality in patients with connective tissue diseases: a systematic review. Clin Rheumatol. 2007; 26:663–70.

2. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, Mootrey G, et al. Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm Rep. 2007; 56:1–54.

3. Kim JH, Choi HN, Kim SH, Lee H, Park SH, Kim SK, et al. Pandemic H1N1 Influenza vaccination responses in rheumatoid arthritis and systemic lupus erythematosus patients. J Rheum Dis. 2013; 20:87–93.

4. Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, et al. Protective effect of A/H1N1 vaccination in immune-mediated disease–a prospectively controlled vaccination study. Rheumatology (Oxford). 2012; 51:695–700.

5. Del Porto F, Laganà B, Biselli R, Donatelli I, Campitelli L, Nisini R, et al. Influenza vaccine administration in patients with systemic lupus erythematosus and rheumatoid arthritis. Safety and immunogenicity. Vaccine. 2006; 24:3217–23.

6. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003; 362:1733–45.

7. Gabay C, Bel M, Combescure C, Ribi C, Meier S, Posfay-Barbe K, et al. H1N1 Study Group. Impact of syn-thetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study. Arthritis Rheum. 2011; 63:1486–96.

8. Aikawa NE, Campos LM, Silva CA, Carvalho JF, Saad CG, Trudes G, et al. Glucocorticoid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease. J Rheumatol. 2012; 39:167–73.

9. Abu-Shakra M, Press J, Varsano N, Levy V, Mendelson E, Sukenik S, et al. Specific antibody response after influenza immunization in systemic lupus erythematosus. J Rheumatol. 2002; 29:2555–7.

10. Saad CG, Borba EF, Aikawa NE, Silva CA, Pereira RM, Calich AL, et al. Immunogenicity and safety of the 2009 non-adjuvanted influenza A/H1N1 vaccine in a large cohort of autoimmune rheumatic diseases. Ann Rheum Dis. 2011; 70:1068–73.

11. Urowitz MB, Anton A, Ibanez D, Gladman DD. Autoantibody response to adjuvant and nonadjuvant H1N1 vaccination in systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011; 63:1517–20.

12. Abu-Shakra M, Press J, Sukenik S, Buskila D. Influenza virus vaccination of patients with SLE: effects on generation of autoantibodies. Clin Rheumatol. 2002; 21:369–72.

13. Schiffer L, Kümpers P, Davalos-Misslitz AM, Haubitz M, Haller H, Anders HJ, et al. B-cell-attracting chemokine CXCL13 as a marker of disease activity and renal involvement in systemic lupus erythematosus (SLE). Nephrol Dial Transplant. 2009; 24:3708–12.

TOOLS

Similar articles